Nicola Broughton

QUBIS Ltd (Qubis) is a venture capital firm, subsidiary of Queen's University of Belfast founded in the year 1984. The firm is headquartered in Belfast, Northern Ireland.

Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom.

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom.

In-Part Publishing Ltd. operates a matchmaking platform for university-industry collaboration. It connects businesses with academics looking for university-industry collaboration, technology transfer and research commercialization partnerships. The company was founded by Patrick Speedie and Robin Knight and is headquartered in Sheffield, the United Kingdom.

Manchester Imaging Ltd. develops dental diagnostic software solutions. It operates as a platform technology underpinning an image analysis software portfolio with development applications in several aspects of dental healthcare. The company was founded by Jim Graham and Hugh Devlin and is headquartered in Manchester, the United Kingdom.

Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom.

Cytomos Ltd. provides rapid label-free cell analysis for biotechnology research and in-vitro diagnostics using dielectric spectroscopy. The firm offers ePad technology which permits detection, identification, and characterization of single cells in real-time as they progress through an experiment. The company was founded by Keith Muir and is headquartered in Edinburgh, the United Kingdom.

Invizius Ltd. develops application for dialysis patients. It offers hemo compatibility for dialyzers. The company was founded by Andrew Herbert on January 26, 2018 and is headquartered in Edinburgh, the United Kingdom.